SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-055420
Filing Date
2021-10-29
Accepted
2021-10-29 16:03:06
Documents
13
Period of Report
2021-10-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea149576-8k_cormedix.htm   iXBRL 8-K 31492
2 LETTER AGREEMENT, DATED AND EFFECTIVE OCTOBER 26, 2021, BETWEEN CORMEDIX INC. AN ea149576ex10-1_cormedix.htm EX-10.1 12829
  Complete submission text file 0001213900-21-055420.txt   221909

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE crmd-20211026.xsd EX-101.SCH 3025
4 XBRL LABEL FILE crmd-20211026_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE crmd-20211026_pre.xml EX-101.PRE 22359
6 EXTRACTED XBRL INSTANCE DOCUMENT ea149576-8k_cormedix_htm.xml XML 3593
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 211363244
SIC: 2834 Pharmaceutical Preparations